Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

153.72 +6.72 (+4.57%)
Streaming Delayed Price Updated: 11:10 AM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Moderna Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
The Threat of Infectious Diseases Impulses Governments and Businesses Towards Adjustments
FinancialBuzz.com News Commentary 
From PR Newswire
Flagship Pioneering Completes Raising a New $1.1 Billion Capital Pool
Fueling the Next Wave of Life Science Innovations and Pioneering Ventures 
From PR Newswire
Thinking about buying stock in Advanced Micro Devices, Aytu Bioscience, Inseego, Moderna, or SuperCom?
InvestorsObserver issues critical PriceWatch Alerts for AMD, AYTU, INSG, MRNA, and SPCB. 
From PR Newswire
Moderna Provides Update on the Impact of COVID-19 on Business Operations and Clinical Program Development
Moderna provides an update on the impact of COVID-19 on business operations and clinical program development. 
From Business Wire News Releases
Thinking about buying stock in Chesapeake Energy Corp, Canadian Solar, Moderna, Micron, or Tenet Healthcare?
InvestorsObserver issues critical PriceWatch Alerts for CHK, CSIQ, MRNA, MU, and THC. 
From PR Newswire
Identifying the Significant Differences Among Head-Start Candidates in Race for Coronavirus Vaccine
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund
Repertoire Immune Medicines, a newly launched company working to unleash the curative power of the immune system to prevent and cure disease, today announced an investment from the JDRF T1D Fund, a... 
From Business Wire News Releases
Moderna to Present at MIT Lecture Series
Moderna to present at MIT Distinguished Lecture Series. 
From Business Wire News Releases
Pharmaceutical Development Ramp up as Viral Infections Continue to Threaten
FinancialBuzz.com News Commentary 
From PR Newswire
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
Financialnewsmedia.com News Commentary 
From PR Newswire
Biotech Companies Concentrate on Vaccine Formulation and Distribution
FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about buying stock in Cognex, Kroger, Moderna, Nio, or Vaxart?
InvestorsObserver issues critical PriceWatch Alerts for CGNX, KR, MRNA, NIO, and VXRT. 
From PR Newswire
Coronavirus Puts Drug Repurposing on the Fast Track
Financialnewsmedia.com News Commentary 
From PR Newswire
Coronavirus Puts Drug Repurposing On The Fast Track
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Moderna Announces First Participant Dosed in NIH-led Phase 1 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
Moderna announces first participant dosed in NIH-led Phase 1 study of mRNA vaccine (mRNA-1273) against novel coronavirus. 
From Business Wire News Releases
Thinking about buying stock in Ford, Moderna, Progressive, AT&T, or Visa?
InvestorsObserver issues critical PriceWatch Alerts for F, MRNA, PGR, T, and V. 
From PR Newswire
Innovations Abound in the Fight Against COVID-19
FinancialBuzz.com News Commentary 
From PR Newswire
Flagship Pioneering Announces the Launch of Repertoire Immune Medicines with Industry Veteran John G. Cox as Chief Executive Officer
Flagship Pioneering, a life sciences innovation enterprise, announced the launch of Repertoire Immune Medicines, a clinical-stage biotechnology company tapping the curative powers of our immune system... 
From Business Wire News Releases
Limiting Coronavirus Exposure, WHO Urging Stepped up Measures to Combat Virus
Financialnewsmedia.com News Commentary 
From PR Newswire
Limiting Coronavirus Exposure, WHO Urging Stepped Up Measures to Combat Virus
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Moderna Completes Enrollment of Cytomegalovirus (CMV) Vaccine (mRNA-1647) Phase 2 Study
Moderna completes enrollment of cytomegalovirus (CMV) vaccine (mRNA-1647) Phase 2 study. 
From Business Wire News Releases
Aggressive Infectious Diseases Prompt the Development of Powerful New Blood Tests
FinancialBuzz.com News Commentary 
From PR Newswire
Moderna Announces Updated Plans for its March 4 Manufacturing & Digital Day Event
Moderna announces updated plans for its March 4 Manufacturing & Digital Day event. 
From Business Wire News Releases
Governments Spring to Action as Coronavirus Fears Grow
FinancialBuzz.com News Commentary 
From PR Newswire
Moderna to Host Manufacturing & Digital Day on March 4, 2020
Moderna to host Manufacturing & Digital Day on March 4 at the Company’s manufacturing facility in Norwood, MA. 
From Business Wire News Releases
Latest Viral Outbreak Reinforces the Need for Modern Containment Measures
FinancialBuzz.com News Commentary 
From PR Newswire
Moderna Reports 2019 Fourth Quarter and Full Year Financial Results and Highlights Advancements in Core Modalities
Moderna reports 2019 fourth quarter and full year financial results and highlights advancements in core modalities. 
From Business Wire News Releases
Moderna Ships mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study
Moderna ships mRNA vaccine against novel coronavirus (mRNA-1273) to the NIH to be used in the planned Phase 1 study in the U.S. 
From Business Wire News Releases
Moderna to Present at Upcoming Investor Conferences
Moderna to present at upcoming investor conferences. 
From Business Wire News Releases
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.